Boston Millennia Partners

BEKhealth specializes in clinical research software that enhances the efficiency of clinical trials and observational studies. The company utilizes an AI-powered platform for chart abstraction and patient matching, which enables organizations to gain deeper insights into their patient populations. By extracting structured and unstructured data from electronic medical records, BEKhealth's technology captures three times more trial criteria, thereby facilitating faster feasibility assessments, optimizing site selection, and identifying clinically qualified participants more effectively. This approach not only accelerates timelines but also aims to increase the number of protocol-eligible candidates significantly, leading to enhanced enrollment processes and reduced costs for clients.

Korio is a compliance-centric platform that specializes in randomization and trial supply management within the clinical research sector. By integrating advanced IRT design intelligence, Korio addresses operational inefficiencies and enhances user experiences, alleviating the burdens of manual processes. The platform features a role-based interface that encompasses functionalities for randomization, trial supply management, and data management, ensuring efficient workflows. Additionally, it provides direct access to the leadership team, allowing users to operate with confidence and streamline their processes effectively.

S2N Health is a consulting firm that specializes in providing strategy consulting services and SaaS solutions tailored for the medical technology sector. Established in 2011, the company has worked with over 160 organizations, ranging from startups to large multinational firms, offering insights and analytics that inform critical product, commercial, and business decisions. S2N Health supports clients across various stages, including product development, market entry, sales acceleration, and strategic partnerships. A key offering is RepSignal, an AI-driven SaaS solution launched in 2022, which provides medtech commercial teams with on-demand customer insights and intelligence, allowing them to effectively target and engage clinical customers. The firm aims to facilitate the growth and success of medical technology innovators by leveraging a network of experts in regulatory, reimbursement, and other relevant disciplines.

KAID Health specializes in artificial intelligence and natural language processing tailored for healthcare organizations. The company has developed an AI-enabled clinical analysis and provider engagement platform that automates various aspects of care management by utilizing comprehensive patient data. This platform identifies gaps in care and integrates them into the providers' workflows, facilitating timely interventions. It serves multiple clinical settings and is designed for diverse use cases, including the automation of quality metric reporting for primary care providers. By streamlining these processes, KAID Health enables care teams to effectively engage patients, allowing clinicians to focus on building empathetic partnerships with them while achieving clinical, operational, and financial goals.

Korio is a compliance-centric platform that specializes in randomization and trial supply management within the clinical research sector. By integrating advanced IRT design intelligence, Korio addresses operational inefficiencies and enhances user experiences, alleviating the burdens of manual processes. The platform features a role-based interface that encompasses functionalities for randomization, trial supply management, and data management, ensuring efficient workflows. Additionally, it provides direct access to the leadership team, allowing users to operate with confidence and streamline their processes effectively.

QuantHealth develops artificial intelligence-based software aimed at enhancing drug development processes. The company's platform conducts patient-centric simulations that integrate various data points from the clinical and drug development landscape. By predicting patient responses to both existing and new therapies, QuantHealth enables pharmaceutical and biotechnology companies to test different clinical trial designs. This capability helps optimize trial strategies, ultimately increasing the chances of successful outcomes. Through its innovative approach, QuantHealth supports the healthcare industry in identifying new clinical opportunities and refining development strategies.

Atropos Health is a technology company based in Palo Alto, California, founded in 2019. It specializes in developing a digital prognostogram platform, known as the Atropos Evidence Platform, which transforms health data into actionable real-world evidence. By integrating electronic medical record (EMR) data, the platform generates digital evidence tailored to individual patient outcomes. This enables healthcare institutions, life science companies, and researchers to utilize previously siloed EMR data effectively. The platform aims to close evidence gaps in healthcare, enhance clinical outcomes through data-driven care, and accelerate research initiatives. Atropos Health serves caregivers, healthcare organizations, and risk-bearing entities, contributing to advancements in evidence-based healthcare.

CubeWorks Inc. specializes in developing millimeter-scale computing solutions, focusing on autonomous wireless sensing technology. Founded in 2013 and based in Ann Arbor, Michigan, the company has created the Cubisens platform, which includes ultra-small wireless smart sensors for various applications such as healthcare logistics, supply chain management, cold chain monitoring, security, and environmental monitoring. These sensors are characterized by their lightweight and durable design, making them suitable for deployment in challenging environments. By enabling real-time tracking and providing critical data access, CubeWorks aims to enhance the Internet of Things (IoT) landscape with innovative sensing solutions that address a wide range of monitoring needs.

KAID Health specializes in artificial intelligence and natural language processing tailored for healthcare organizations. The company has developed an AI-enabled clinical analysis and provider engagement platform that automates various aspects of care management by utilizing comprehensive patient data. This platform identifies gaps in care and integrates them into the providers' workflows, facilitating timely interventions. It serves multiple clinical settings and is designed for diverse use cases, including the automation of quality metric reporting for primary care providers. By streamlining these processes, KAID Health enables care teams to effectively engage patients, allowing clinicians to focus on building empathetic partnerships with them while achieving clinical, operational, and financial goals.

Huma.AI, Inc. is a technology company based in Palo Alto, California, that focuses on developing a knowledge automation platform designed to enhance efficiency in the healthcare and pharmaceutical industries. Founded in 2016, the company addresses the challenges posed by disparate systems and the vast amounts of unstructured data that complicate decision-making. By serving as a connector between data silos, Huma.AI enables users to access insights and actionable information through natural language queries. The platform is capable of extracting valuable insights from various document formats, allowing companies, scientists, and clinicians to make informed decisions quickly and effectively. Through this innovative approach, Huma.AI aims to streamline healthcare processes and improve overall operational efficiency.

Reveleer is a healthcare software and services company that operates a Software-as-a-Service analytics platform focused on medical record analysis and targeted solutions. Founded in 2009 and based in Glendale, California, the company enables payers across Medicare, Medicaid, and commercial sectors to effectively manage risk adjustment and quality improvement programs. Reveleer's platform provides a comprehensive suite of services, including medical record collection, retrieval, coding, and abstraction, all integrated into a single system. Additionally, the company offers professional services such as abstractor training, auditing, and strategic assessments to enhance operational practices and data management. Formerly known as Health Data Vision, Inc., Reveleer rebranded in August 2019 to reflect its commitment to empowering healthcare organizations to take control of their data and improve coding accuracy.

CareAlign offers a patient-centric task management tool that assists clinicians in tracking, managing, and coordinating clinical care. The platform provides an intuitive interface for assigning tasks with specific dates and times, categorizing them by urgency, and reviewing completed tasks. Additionally, CareAlign has developed a real-time data system that consolidates information from various sources into a cohesive and easily navigable display. This system enhances clinicians' understanding of patients' clinical statuses, ultimately improving care coordination.

BEKhealth specializes in clinical research software that enhances the efficiency of clinical trials and observational studies. The company utilizes an AI-powered platform for chart abstraction and patient matching, which enables organizations to gain deeper insights into their patient populations. By extracting structured and unstructured data from electronic medical records, BEKhealth's technology captures three times more trial criteria, thereby facilitating faster feasibility assessments, optimizing site selection, and identifying clinically qualified participants more effectively. This approach not only accelerates timelines but also aims to increase the number of protocol-eligible candidates significantly, leading to enhanced enrollment processes and reduced costs for clients.

Clinical Research IO is a health technology company based in Boston, Massachusetts, that specializes in developing e-source and site operation software for clinical research sites. The company's software allows users to create and customize clinical trial documentation using a library of pre-developed templates, while also detecting and correcting source data errors. Additionally, it includes features for managing patient compliance, such as scheduling and text reminders, as well as modules for patient scheduling and recruitment, aimed at enhancing participant retention and recruitment efforts. By providing a unified system for data capture, Clinical Research IO facilitates the regulatory workflows of pharmaceutical companies, biotechnology firms, research sites, and academic research centers, thereby streamlining the overall clinical research process.

Turbine Ltd is a biotechnology company based in Budapest, Hungary, founded in 2015. It specializes in the development of computational models that predict biological and clinical outcomes to aid in cancer drug development. Utilizing its proprietary Simulated Cell technology alongside artificial intelligence, Turbine focuses on understanding the intricate mechanisms of cancer. This approach facilitates the discovery of novel protein targets and precision biomarkers, enhancing the translation of research to patient care. The company also creates cancer combination therapies that clarify the underlying biology of diseases and personalize treatment options. By leveraging bioinformatics and network medicine, Turbine effectively simulates complex interventions, allowing for the screening of numerous drug combinations on simulated cells. This innovative process aims to provide cancer patients with low-cost and effective treatment plans.

SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

Cecelia Health, Inc. is a technology-enabled company based in New York that specializes in remote telehealth support and chronic disease management, particularly focusing on diabetes care. Founded in 2006 and formerly known as Fit4D, the company provides clinical support and coaching services for individuals with Type 1 and Type 2 diabetes, as well as those managing other chronic conditions such as obesity and cardiovascular disease. Cecelia Health combines expert clinical coaching with digital health tools to enhance patient adherence to medications and wellness programs. The company's approach emphasizes personalized coaching and patient engagement, utilizing both virtual care and telehealth solutions to improve health outcomes. Through its services, Cecelia Health aims to transform the lives of its patients by fostering better self-management and promoting positive behavior changes.

CareAlign offers a patient-centric task management tool that assists clinicians in tracking, managing, and coordinating clinical care. The platform provides an intuitive interface for assigning tasks with specific dates and times, categorizing them by urgency, and reviewing completed tasks. Additionally, CareAlign has developed a real-time data system that consolidates information from various sources into a cohesive and easily navigable display. This system enhances clinicians' understanding of patients' clinical statuses, ultimately improving care coordination.

Digital Cognition Technologies, Inc. specializes in the research and development of non-invasive tests designed to detect presymptomatic cognitive impairment. The company’s innovative approach involves analyzing micro-movements in drawing behavior, which provide insights into an individual's memory and thinking processes. These tests are utilized in various contexts, including drug development, where they facilitate the pre-screening of participants and help assess the efficacy of treatments by identifying subtle cognitive changes. Additionally, the tests support researchers in early detection and intervention strategies, enabling timely treatment with both investigational therapies and established medications. Founded in 2015 and based in Waltham, Massachusetts, Digital Cognition Technologies aims to enhance patient care and improve treatment outcomes through early identification of cognitive decline.

iQuartic, Inc. develops cloud-based platforms aimed at enhancing data management within the healthcare industry. The company's technology facilitates electronic health record (EHR) and claims auditing, quality benchmarking, population health management, and risk profiling. Key offerings include the iQ EHR Network, which integrates disparate electronic medical record (EMR) systems; iQ EHR Auditing, which employs advanced analytics to identify inconsistencies in EHR and claims data; and iQ ACO Software, designed for accountable care organizations to gain insights into patient networks. Additional products include the EHR Data Auditor, which models patient behavior to identify under-reported cases, and the Diabetes Management Scorecard for assessing diabetes management across various EMRs. iQuartic also provides tools for chronic disease management, predicting hospital readmissions, and profiling clinicians. Established in 2012, the company operates from Boston, Massachusetts.

Health Decisions, Inc. is a full-service clinical research organization based in Durham, North Carolina, that specializes in clinical studies related to women's health and diagnostics across various therapeutic areas. Founded in 1989, the company has conducted over 100 trials focusing primarily on women's health issues such as contraception and postmenopausal symptoms. In recent years, Health Decisions has expanded its expertise to include diagnostics studies, notably a significant PMA study for high-risk HPV types related to cervical cancer. The company offers a comprehensive suite of services including project management, medical writing, data management, biostatistics, regulatory compliance, and strategic consulting. By providing tailored solutions to its partners, Health Decisions aims to facilitate the rapid and efficient development of women's health products and diagnostic tests, helping clients achieve their business objectives with minimal risk.

Reveleer is a healthcare software and services company that operates a Software-as-a-Service analytics platform focused on medical record analysis and targeted solutions. Founded in 2009 and based in Glendale, California, the company enables payers across Medicare, Medicaid, and commercial sectors to effectively manage risk adjustment and quality improvement programs. Reveleer's platform provides a comprehensive suite of services, including medical record collection, retrieval, coding, and abstraction, all integrated into a single system. Additionally, the company offers professional services such as abstractor training, auditing, and strategic assessments to enhance operational practices and data management. Formerly known as Health Data Vision, Inc., Reveleer rebranded in August 2019 to reflect its commitment to empowering healthcare organizations to take control of their data and improve coding accuracy.

Forefront TeleCare, Inc. is a leading provider of HIPAA-compliant telehealth services focused on behavioral health care in the United States. Founded in 2005 and based in Novato, California, the company specializes in delivering telepsychiatry, telepsychology, and telepsychotherapy services, particularly to small and rural healthcare facilities. Forefront TeleCare offers a comprehensive solution that includes in-facility equipment, training, scheduling, and technical support, ensuring secure and reliable audio/video connections between healthcare providers and patients. The company serves a diverse client base, including skilled nursing facilities and clinics across 18 states, and collaborates with a network of psychiatrists, clinical psychologists, and psychiatric nurse practitioners. By integrating behavioral health support into the overall care team, Forefront TeleCare aims to enhance the quality of life for seniors and individuals requiring psychiatric services.

Roobrik, Inc. is a company that specializes in providing online assessment and decision tools aimed at assisting older adults, their caregivers, and senior care providers in making informed health and care choices. Founded in 2013 and headquartered in Greensboro, North Carolina, Roobrik's tools focus on simplifying the often complex process of later-life decision-making. They help families navigate critical issues such as driving safety, home safety, and managing dementia, ultimately promoting better health and wellness outcomes while also reducing costs associated with long-term care. By prioritizing informed decision-making, Roobrik empowers users to make choices that enhance their quality of life and care.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

Mingle Health is a healthcare informatics company established in 2011 and based in Sandy, Utah. The company has developed an end-to-end quality-improvement platform designed to enhance data collection, reporting, and preventive care within the healthcare system. Mingle Health's platform focuses on making healthcare affordable and ensuring that practices remain profitable. It offers streamlined reporting and consulting services tailored to healthcare organizations of all sizes, assisting them in optimizing practice management and designing quality improvement programs that align with regulatory requirements. Through its solutions, Mingle Health aims to improve care delivery, reduce costs, and transform healthcare operations, ultimately enhancing both the joy and profitability of medical practices.

C2Sense, Inc. specializes in developing chemiresistive gas sensors and miniaturized sensing technologies aimed at enhancing food quality and safety, particularly in the food and agriculture sectors. Founded in 2013 and based in Cambridge, Massachusetts, the company’s sensors detect gases like ethylene and biogenic amines at low concentrations, allowing stakeholders throughout the supply chain—from growers to consumers—to monitor the freshness of fruits, meats, and other perishable goods, ultimately reducing waste. C2Sense is also advancing its Halo Diagnostics product, a digitally connected immunoassay reader that offers near-PCR sensitivity and facilitates real-time test results through a cloud-based, HIPAA-compliant platform. This technology supports remote healthcare by enabling physicians to access patient test results instantly. Additionally, C2Sense has developed versatile sensing solutions that provide product quality information and counterfeit detection, using safe molecular additives that report on the status of goods throughout the distribution process, thereby enhancing security in various sectors, including pharmaceuticals and luxury goods.

Bivarus, Inc. is a Durham, North Carolina-based company that specializes in developing a cloud-based analytics platform aimed at enhancing the patient experience in healthcare settings. Founded in 2010, Bivarus emerged from academic research that established patient experience as a key factor in determining health outcomes. The platform provides healthcare leaders with real-time, actionable insights into factors affecting patient experience, provider performance, and overall service operations. By utilizing a sophisticated sampling algorithm, Bivarus delivers targeted measures to patients, enabling organizations to identify root causes of service issues and track quality improvement initiatives effectively. Additionally, Bivarus is recognized as a CMS-approved CAHPS® partner, offering comprehensive services that include measuring employee perceptions of organizational effectiveness and engagement. As a subsidiary of Press Ganey Holdings, Inc., Bivarus continues to play a pivotal role in transforming how healthcare organizations understand and enhance the patient experience.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

BC Platforms provides a data and technology platform designed for life sciences and healthcare companies to access, manage, and analyze clinical and omics data. Its Data Access Platform offers valuable resources, including real-world data, clinical data, and genomic information, through a data-as-a-service model. The company's Data Partner Network encompasses over 22 million life-years of meticulously curated patient data from various global sources. This extensive data access allows pharmaceutical companies to enhance research and development processes, accelerating the transition from early discovery to clinical and post-market evaluations. BC Platforms also offers technology solutions that enable healthcare providers and life science organizations to manage and analyze complex genomic data, ensuring compliance with local privacy regulations and compatibility with relevant technical standards. Through its innovative platform, BC Platforms aims to improve decision-making in drug development and delivery, helping to address significant health challenges effectively.

Bivarus, Inc. is a Durham, North Carolina-based company that specializes in developing a cloud-based analytics platform aimed at enhancing the patient experience in healthcare settings. Founded in 2010, Bivarus emerged from academic research that established patient experience as a key factor in determining health outcomes. The platform provides healthcare leaders with real-time, actionable insights into factors affecting patient experience, provider performance, and overall service operations. By utilizing a sophisticated sampling algorithm, Bivarus delivers targeted measures to patients, enabling organizations to identify root causes of service issues and track quality improvement initiatives effectively. Additionally, Bivarus is recognized as a CMS-approved CAHPS® partner, offering comprehensive services that include measuring employee perceptions of organizational effectiveness and engagement. As a subsidiary of Press Ganey Holdings, Inc., Bivarus continues to play a pivotal role in transforming how healthcare organizations understand and enhance the patient experience.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.

G-Form, LLC, founded in 2010 and based in Providence, Rhode Island, specializes in the manufacture of innovative protective equipment and solutions for both athletic and consumer electronic applications. The company offers a range of protective products including knee pads, elbow guards, compression shorts, and various accessories for sports such as baseball, soccer, hockey, and mountain biking. G-Form's products are designed to be lightweight and to harden upon impact, providing high-level protection while ensuring comfort and freedom of movement. In addition to sports gear, G-Form also produces protective cases for laptops, iPads, iPhones, and tablets. The company distributes its products through retailers and distributors both domestically and internationally, as well as through its online platform in the United States.

Avhana Health Inc. is a provider of a clinical decision support platform designed to enhance healthcare provider workflows. Founded in 2014 and headquartered in Baltimore, Maryland, the company offers a software application that integrates directly with electronic health records (EHR). This platform simplifies the healthcare process by delivering the latest clinical guidelines, actionable recommendations, and performance metrics. It includes features such as a dashboard for pre-visit planning, patient-specific care recommendations, order suggestions that can be submitted directly to the EHR, and tools for tracking provider activity and performance. By focusing on value-based care enablement, Avhana Health aims to deliver impactful support to healthcare teams, ultimately improving quality of care and reducing healthcare costs.

Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.

Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.

PreCision Dermatology is a fully-integrated dermatology company focused on delivering innovative therapies that enhance skin care for both doctors and patients. The company specializes in developing dermatological products, including a drug delivery platform designed to improve the efficacy of active ingredients while minimizing side effects and enhancing the natural skin barrier. This technology enables the treatment of various dermatological conditions, such as atopic dermatitis, acne, and rosacea. PreCision Dermatology is experiencing rapid growth through a combination of internal innovation, acquisitions, in-licensing, and co-marketing strategies, positioning itself as a key player in the skincare industry.

Histogenics Corporation, founded in 2000 and headquartered in Waltham, Massachusetts, is a regenerative medicine company specializing in the development and commercialization of therapeutic medical products for musculoskeletal conditions. The company's innovative platform integrates cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to address cartilage damage and improve joint function. Its primary investigational product, NeoCart, is a tissue implant designed to treat cartilage injuries in the knee, aiming to regenerate healthy cartilage and enhance overall joint performance. In 2019, Histogenics was acquired by Ocugen, Inc., marking a significant transition in its corporate structure.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.

NuVox is a provider of voice and data network communications, primarily serving businesses in the United States. The company offers a range of services, including broadband access, conference calling, data security and backup, voicemail, and web hosting. By delivering comprehensive communication solutions, NuVox enables organizations to enhance their operational efficiency and connectivity.

Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.

SensorLogic is a provider of cloud-based machine-to-machine (M2M) application hosting services, specializing in platform-as-a-service (PaaS) solutions. The company offers a comprehensive service delivery platform that includes open device and network management, business logic, and application services. This enables organizations to create and deploy customizable M2M applications that leverage connected devices. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the seamless integration of M2M technologies, allowing businesses to enhance operational efficiency and improve service delivery.

Nexidia Inc. specializes in audio and video analysis technologies designed to optimize media interactions. The company offers a variety of solutions, including Nexidia Interaction Analytics, which helps users synthesize and analyze multichannel contact center communications. Other products include Nexidia Capture for call recording, Nexidia Scan and Agent Assist for real-time monitoring, and Nexidia Dialogue Search, which allows content producers to search for specific phrases within audio content. Additionally, Nexidia provides quality control tools for captioning, automation solutions for video compliance, and advanced tools for audio discovery and organization. The company serves a diverse range of industries, including communications, finance, healthcare, and legal sectors, enabling them to unlock the value of unstructured audio and video data. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia operates as a subsidiary of NICE Systems Ltd.

CardioMEMS is a medical device company focused on the development and commercialization of proprietary wireless sensing and communication technology aimed at enhancing the management of severe chronic cardiovascular diseases, including heart failure, hypertension, and aneurysms. The company's innovative platform features miniature wireless sensors that can be implanted using minimally invasive techniques. These sensors transmit vital data, such as cardiac output, blood pressure, and heart rate, which are essential for effective patient management. By providing continuous monitoring, CardioMEMS' technology aims to improve patient outcomes and facilitate timely medical interventions.

Coapt Systems, Inc. specializes in the design, development, and manufacturing of bio-absorbable implants intended for soft tissue fixation in facial cosmetic surgery. Its product offerings include various fixation devices such as the ENDOTINE Forehead 3.0 and ENDOTINE Midface ST 4.5, which are employed in procedures like forehead lifts, brow lifts, and midface suspensions. The company also provides surgical instruments and tools, including insertion kits and manual drills, to facilitate the use of its implants. Coapt Systems aims to support surgeons in achieving effective and secure tissue fixation during surgical procedures, enhancing outcomes for patients undergoing cosmetic interventions.

CardioMEMS is a medical device company focused on the development and commercialization of proprietary wireless sensing and communication technology aimed at enhancing the management of severe chronic cardiovascular diseases, including heart failure, hypertension, and aneurysms. The company's innovative platform features miniature wireless sensors that can be implanted using minimally invasive techniques. These sensors transmit vital data, such as cardiac output, blood pressure, and heart rate, which are essential for effective patient management. By providing continuous monitoring, CardioMEMS' technology aims to improve patient outcomes and facilitate timely medical interventions.

MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.

Histogenics Corporation, founded in 2000 and headquartered in Waltham, Massachusetts, is a regenerative medicine company specializing in the development and commercialization of therapeutic medical products for musculoskeletal conditions. The company's innovative platform integrates cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to address cartilage damage and improve joint function. Its primary investigational product, NeoCart, is a tissue implant designed to treat cartilage injuries in the knee, aiming to regenerate healthy cartilage and enhance overall joint performance. In 2019, Histogenics was acquired by Ocugen, Inc., marking a significant transition in its corporate structure.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.

SensorLogic is a provider of cloud-based machine-to-machine (M2M) application hosting services, specializing in platform-as-a-service (PaaS) solutions. The company offers a comprehensive service delivery platform that includes open device and network management, business logic, and application services. This enables organizations to create and deploy customizable M2M applications that leverage connected devices. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the seamless integration of M2M technologies, allowing businesses to enhance operational efficiency and improve service delivery.

Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures implant systems for various joints, including the knee, shoulder, wrist, hip, foot and ankle, and toe, aimed at treating conditions related to trauma, injury, and arthritis. Its products are engineered to preserve native joint anatomy and biomechanics, allowing for improved range of motion and reduced pain. Arthrosurface's innovations, such as the HemiCAP system, enable patients to undergo procedures with shorter hospital stays and quicker recoveries, facilitating a return to active lifestyles. The company markets its devices through a network of sales representatives and distributors both in the United States and internationally. Since February 2020, Arthrosurface has operated as a subsidiary of Anika Therapeutics, Inc.

MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.

CardioMEMS is a medical device company focused on the development and commercialization of proprietary wireless sensing and communication technology aimed at enhancing the management of severe chronic cardiovascular diseases, including heart failure, hypertension, and aneurysms. The company's innovative platform features miniature wireless sensors that can be implanted using minimally invasive techniques. These sensors transmit vital data, such as cardiac output, blood pressure, and heart rate, which are essential for effective patient management. By providing continuous monitoring, CardioMEMS' technology aims to improve patient outcomes and facilitate timely medical interventions.

Infotrieve, Inc. is an information management company that specializes in providing consulting and business service solutions for information centers within large and middle-market corporations. Founded in 1987 and headquartered in Wilton, Connecticut, Infotrieve offers a range of services including document delivery, library staffing, and information management. Its products include STM Library for collection management in the scientific, technical, and medical sectors, and Virtual Library 2.0, an automated document sourcing and delivery platform. Additionally, the company provides Ariel Interlibrary Loan Document Transmission Software, which facilitates document transmission via the Internet, and copyright compliance services. Infotrieve also delivers enterprise-level content sourcing and management solutions through its Content SCM service, along with tools for product and marketing managers such as reprints, eprints, and eDetailing. Its flagship Mobile Library service enhances content access and management on mobile platforms, further solidifying Infotrieve's position in the information management industry.

Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures implant systems for various joints, including the knee, shoulder, wrist, hip, foot and ankle, and toe, aimed at treating conditions related to trauma, injury, and arthritis. Its products are engineered to preserve native joint anatomy and biomechanics, allowing for improved range of motion and reduced pain. Arthrosurface's innovations, such as the HemiCAP system, enable patients to undergo procedures with shorter hospital stays and quicker recoveries, facilitating a return to active lifestyles. The company markets its devices through a network of sales representatives and distributors both in the United States and internationally. Since February 2020, Arthrosurface has operated as a subsidiary of Anika Therapeutics, Inc.

Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.

Xconomy, Inc. is a media company that delivers business, life sciences, and technology news across various U.S. cities, including Boston, Seattle, San Diego, and New York. Established in 2007 and headquartered in Cambridge, Massachusetts, Xconomy provides insights into local personalities, companies, and technological trends, catering to an audience that includes entrepreneurs, investors, legal professionals, and university officials. The company is recognized for its role in covering the exponential economy, which is defined by rapid technological growth and its impact on productivity and economic development. Xconomy disseminates its content through a network of localized news sites, events, and conferences, ensuring that its audience remains informed about the latest developments in the business and technology sectors. Additionally, Xconomy offers advertising opportunities, including banner ads and underwriting programs, to enhance engagement with its content.

SensorLogic is a provider of cloud-based machine-to-machine (M2M) application hosting services, specializing in platform-as-a-service (PaaS) solutions. The company offers a comprehensive service delivery platform that includes open device and network management, business logic, and application services. This enables organizations to create and deploy customizable M2M applications that leverage connected devices. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the seamless integration of M2M technologies, allowing businesses to enhance operational efficiency and improve service delivery.

Coapt Systems, Inc. specializes in the design, development, and manufacturing of bio-absorbable implants intended for soft tissue fixation in facial cosmetic surgery. Its product offerings include various fixation devices such as the ENDOTINE Forehead 3.0 and ENDOTINE Midface ST 4.5, which are employed in procedures like forehead lifts, brow lifts, and midface suspensions. The company also provides surgical instruments and tools, including insertion kits and manual drills, to facilitate the use of its implants. Coapt Systems aims to support surgeons in achieving effective and secure tissue fixation during surgical procedures, enhancing outcomes for patients undergoing cosmetic interventions.

CardioMEMS is a medical device company focused on the development and commercialization of proprietary wireless sensing and communication technology aimed at enhancing the management of severe chronic cardiovascular diseases, including heart failure, hypertension, and aneurysms. The company's innovative platform features miniature wireless sensors that can be implanted using minimally invasive techniques. These sensors transmit vital data, such as cardiac output, blood pressure, and heart rate, which are essential for effective patient management. By providing continuous monitoring, CardioMEMS' technology aims to improve patient outcomes and facilitate timely medical interventions.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.

Nexidia Inc. specializes in audio and video analysis technologies designed to optimize media interactions. The company offers a variety of solutions, including Nexidia Interaction Analytics, which helps users synthesize and analyze multichannel contact center communications. Other products include Nexidia Capture for call recording, Nexidia Scan and Agent Assist for real-time monitoring, and Nexidia Dialogue Search, which allows content producers to search for specific phrases within audio content. Additionally, Nexidia provides quality control tools for captioning, automation solutions for video compliance, and advanced tools for audio discovery and organization. The company serves a diverse range of industries, including communications, finance, healthcare, and legal sectors, enabling them to unlock the value of unstructured audio and video data. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia operates as a subsidiary of NICE Systems Ltd.

Athenix is a prominent player in the field of agricultural and industrial biotechnology, specializing in the development of products, technologies, and processes tailored for agricultural and chemical applications. The company is dedicated to discovering new genes and transforming them into practical solutions that address specific customer requirements. Athenix focuses on creating plants, microbes, enzymes, and processes aimed at enhancing insect and nematode resistance, as well as herbicide tolerance. Additionally, its research extends to the identification of genes and proteins utilized in the chemical and animal feed industries, reinforcing its commitment to innovation in biotechnology.

GlycoFi is a biotech firm based in Lebanon, New Hampshire, focused on developing biotherapeutics through its innovative glycan optimization technology. The company has engineered a library of yeast strains that enable precise human glycosylation, resulting in therapeutic proteins suitable for drug development. GlycoFi aims to establish its own pipeline of therapeutic products while also collaborating with other pharmaceutical companies to enhance their drug offerings. Founded in 2000, GlycoFi operates as a subsidiary of Merck & Co., Inc., further expanding its capabilities in the biotherapeutics landscape.

Nexidia Inc. specializes in audio and video analysis technologies designed to optimize media interactions. The company offers a variety of solutions, including Nexidia Interaction Analytics, which helps users synthesize and analyze multichannel contact center communications. Other products include Nexidia Capture for call recording, Nexidia Scan and Agent Assist for real-time monitoring, and Nexidia Dialogue Search, which allows content producers to search for specific phrases within audio content. Additionally, Nexidia provides quality control tools for captioning, automation solutions for video compliance, and advanced tools for audio discovery and organization. The company serves a diverse range of industries, including communications, finance, healthcare, and legal sectors, enabling them to unlock the value of unstructured audio and video data. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia operates as a subsidiary of NICE Systems Ltd.

Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

Netifice Communications is redefining how Managed Service Providers deliver secure IP data and voice communication services.

Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures implant systems for various joints, including the knee, shoulder, wrist, hip, foot and ankle, and toe, aimed at treating conditions related to trauma, injury, and arthritis. Its products are engineered to preserve native joint anatomy and biomechanics, allowing for improved range of motion and reduced pain. Arthrosurface's innovations, such as the HemiCAP system, enable patients to undergo procedures with shorter hospital stays and quicker recoveries, facilitating a return to active lifestyles. The company markets its devices through a network of sales representatives and distributors both in the United States and internationally. Since February 2020, Arthrosurface has operated as a subsidiary of Anika Therapeutics, Inc.

Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.

Fast Channel Network is a technology-driven company that provides innovative solutions for the advertising and B2B sectors. It offers a comprehensive suite of tools through its FastChannel Intelligence and Control platform, which includes features for competitor tracking, creative resource management, broadcast verification, and digital asset management. The company also operates an extensive online media distribution network, connecting over 5,000 advertisers and agencies to more than 21,000 online broadcast and publishing destinations. Additionally, Fast Channel focuses on digitizing B2B sales channels for medium and large enterprises, importers, and distributors, helping them enhance their online sales through a specialized e-commerce platform and integrated marketplace solutions.

SensorLogic is a provider of cloud-based machine-to-machine (M2M) application hosting services, specializing in platform-as-a-service (PaaS) solutions. The company offers a comprehensive service delivery platform that includes open device and network management, business logic, and application services. This enables organizations to create and deploy customizable M2M applications that leverage connected devices. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the seamless integration of M2M technologies, allowing businesses to enhance operational efficiency and improve service delivery.

Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.

Tropos Networks designs and supplies technology for building extensive wireless broadband networks suitable for various applications, including smart grid and outdoor industrial use. Their products allow network operators, service providers, and government entities to establish reliable metro-scale Wi-Fi networks without the need for wired connections at each node, significantly reducing installation and operational costs. The company's MetroMesh OS enhances network performance through features such as predictive wireless routing, adaptive mesh connectivity, and self-organizing capabilities. This innovative approach provides users with broad and efficient wireless data coverage in diverse environments, making Tropos a key player in the development of scalable and secure wireless infrastructure.

Continuum Photonics specializes in the development of optical layer connectivity products designed for managing and switching fiber-based optical networks. The company focuses on providing manufacturers of optical networking equipment with innovative subsystems that enhance bandwidth capabilities and facilitate revenue-generating services at reduced costs. Key offerings include single-mode and multi-mode optical matrix switches, carrier optical monitor switches, and latching switches. Continuum Photonics is also advancing a novel photonic switch aimed at addressing various challenges related to the delivery and management of optically-transported bandwidth, which underscores its commitment to creating operational and economic efficiencies in the optical networking sector.

CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on developing drug candidates for the treatment of pain and inflammation. The company leverages its expertise in ion-channel modulation to discover innovative therapeutics, both for its internal product pipelines and in collaboration with other entities. Zalicus invests significantly in research and development, including preclinical and clinical trials, while also pursuing intellectual property protection for its technologies and product candidates. One of its notable achievements includes the FDA approval of Exalgo, an extended-release formulation of hydromorphone HCl, which is indicated for managing moderate to severe pain in opioid-tolerant patients. The company was formed following the merger with Neuromed Pharmaceuticals in December 2009.

Athenix is a prominent player in the field of agricultural and industrial biotechnology, specializing in the development of products, technologies, and processes tailored for agricultural and chemical applications. The company is dedicated to discovering new genes and transforming them into practical solutions that address specific customer requirements. Athenix focuses on creating plants, microbes, enzymes, and processes aimed at enhancing insect and nematode resistance, as well as herbicide tolerance. Additionally, its research extends to the identification of genes and proteins utilized in the chemical and animal feed industries, reinforcing its commitment to innovation in biotechnology.

Infotrieve, Inc. is an information management company that specializes in providing consulting and business service solutions for information centers within large and middle-market corporations. Founded in 1987 and headquartered in Wilton, Connecticut, Infotrieve offers a range of services including document delivery, library staffing, and information management. Its products include STM Library for collection management in the scientific, technical, and medical sectors, and Virtual Library 2.0, an automated document sourcing and delivery platform. Additionally, the company provides Ariel Interlibrary Loan Document Transmission Software, which facilitates document transmission via the Internet, and copyright compliance services. Infotrieve also delivers enterprise-level content sourcing and management solutions through its Content SCM service, along with tools for product and marketing managers such as reprints, eprints, and eDetailing. Its flagship Mobile Library service enhances content access and management on mobile platforms, further solidifying Infotrieve's position in the information management industry.

Galt is an international leader in helping clients manage risk through information. Galt's evidence-based solutions integrate the recognized expertise of its medical and scientific personnel with innovative technologies to ensure timely answers to clients' critical questions. This integrated approach allows Galt to deliver medical risk management and communication strategies that address the benefits and risks associated with the full range of medical therapies and interventions. Galt supports more than 70 pharmaceutical, medical device and biotechnology companies, as well as contract research organizations (CRO) and research institutions located throughout the U.S. and Europe

Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.

Nexidia Inc. specializes in audio and video analysis technologies designed to optimize media interactions. The company offers a variety of solutions, including Nexidia Interaction Analytics, which helps users synthesize and analyze multichannel contact center communications. Other products include Nexidia Capture for call recording, Nexidia Scan and Agent Assist for real-time monitoring, and Nexidia Dialogue Search, which allows content producers to search for specific phrases within audio content. Additionally, Nexidia provides quality control tools for captioning, automation solutions for video compliance, and advanced tools for audio discovery and organization. The company serves a diverse range of industries, including communications, finance, healthcare, and legal sectors, enabling them to unlock the value of unstructured audio and video data. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia operates as a subsidiary of NICE Systems Ltd.

CardioMEMS is a medical device company focused on the development and commercialization of proprietary wireless sensing and communication technology aimed at enhancing the management of severe chronic cardiovascular diseases, including heart failure, hypertension, and aneurysms. The company's innovative platform features miniature wireless sensors that can be implanted using minimally invasive techniques. These sensors transmit vital data, such as cardiac output, blood pressure, and heart rate, which are essential for effective patient management. By providing continuous monitoring, CardioMEMS' technology aims to improve patient outcomes and facilitate timely medical interventions.

Protein Forest, Inc. specializes in the development, manufacturing, and marketing of instruments, consumables, and software products aimed at protein separation and bioanalysis applications. Based in Lexington, Massachusetts, the company provides innovative solutions such as the digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides through isoelectric focusing, facilitating mass spectrometry analysis and western blotting. Its product lineup includes the dPC fractionator, designed to process separate samples under controlled conditions, and the dPC PlugHarvestor, which enables users to organize pH gel plugs efficiently. Additionally, Protein Forest offers bioinformatics software that complements its hardware solutions. The company serves a diverse clientele in the life sciences, drug discovery, pharmaceutical, biotech, and diagnostic sectors, contributing to advancements in research and development since its founding in 2002.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.

PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers advanced technologies, including the LogPad and StudyPad systems, which enhance data quality and support efficient data capture and management. PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to critical trial data, facilitating informed decision-making. By partnering with biopharmaceutical and medical device companies, PHT enables more effective and accurate clinical studies, ultimately contributing to the success of trials.

Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures implant systems for various joints, including the knee, shoulder, wrist, hip, foot and ankle, and toe, aimed at treating conditions related to trauma, injury, and arthritis. Its products are engineered to preserve native joint anatomy and biomechanics, allowing for improved range of motion and reduced pain. Arthrosurface's innovations, such as the HemiCAP system, enable patients to undergo procedures with shorter hospital stays and quicker recoveries, facilitating a return to active lifestyles. The company markets its devices through a network of sales representatives and distributors both in the United States and internationally. Since February 2020, Arthrosurface has operated as a subsidiary of Anika Therapeutics, Inc.

Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.

Entigo is a company that specializes in enterprise warranty chain management solutions, offering a suite of products designed to streamline warranty processes for businesses. Its flagship product, Entigo Warranty, allows organizations to manage warranty processing efficiently, while Entigo Catalyst provides strategic evaluations of existing warranty operations. The company also offers a range of consulting services, including project management, warranty process reengineering, systems integration, and training. These solutions automate key functions such as registration and claims handling, improving the speed of claims adjudication and problem resolution. By providing analytics and reporting capabilities, Entigo helps businesses enhance product quality and reduce warranty costs. The company's systems are designed to minimize errors and inefficiencies, ensuring seamless integration with warranty chain partners. Serving a diverse clientele, including Fortune 500 manufacturers in various industries such as automotive, aerospace, and electronics, Entigo aims to simplify warranty management and support operational excellence. Founded in 1995 and headquartered in Exton, Pennsylvania, Entigo is committed to delivering innovative solutions that meet the evolving needs of its customers.

Tropos Networks designs and supplies technology for building extensive wireless broadband networks suitable for various applications, including smart grid and outdoor industrial use. Their products allow network operators, service providers, and government entities to establish reliable metro-scale Wi-Fi networks without the need for wired connections at each node, significantly reducing installation and operational costs. The company's MetroMesh OS enhances network performance through features such as predictive wireless routing, adaptive mesh connectivity, and self-organizing capabilities. This innovative approach provides users with broad and efficient wireless data coverage in diverse environments, making Tropos a key player in the development of scalable and secure wireless infrastructure.

NuVox is a provider of voice and data network communications, primarily serving businesses in the United States. The company offers a range of services, including broadband access, conference calling, data security and backup, voicemail, and web hosting. By delivering comprehensive communication solutions, NuVox enables organizations to enhance their operational efficiency and connectivity.

Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

Nexidia Inc. specializes in audio and video analysis technologies designed to optimize media interactions. The company offers a variety of solutions, including Nexidia Interaction Analytics, which helps users synthesize and analyze multichannel contact center communications. Other products include Nexidia Capture for call recording, Nexidia Scan and Agent Assist for real-time monitoring, and Nexidia Dialogue Search, which allows content producers to search for specific phrases within audio content. Additionally, Nexidia provides quality control tools for captioning, automation solutions for video compliance, and advanced tools for audio discovery and organization. The company serves a diverse range of industries, including communications, finance, healthcare, and legal sectors, enabling them to unlock the value of unstructured audio and video data. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia operates as a subsidiary of NICE Systems Ltd.

WebCT, Inc. is a prominent provider of e-learning solutions tailored for higher education institutions, colleges, and universities. Founded with the vision of creating a flexible and integrated learning environment, WebCT aims to enhance student engagement through technology that promotes inquiry, discourse, and collaboration. The company offers a comprehensive suite of learning management solutions that seamlessly integrate advanced pedagogical tools with existing campus infrastructure. In addition to its core products, WebCT provides various support services, including technical assistance, professional development, and hosting, which collectively simplify and enrich the educational experience for students worldwide. Through its innovative solutions, WebCT is committed to advancing educational excellence in the higher education sector.

TechSmart.com (the "Company"), formed in April 1997 under the name Linx Technologies, offers original equipment manufacturers, lessors, retailers, e-tailers and large corporations a web-based asset recovery solution ("Assets into Money") to effectively manage and resell their returned, refreshed, off-lease and overstock office technology assets ("recovered assets"). These businesses, which They call SmartPartners, send their technology assets to TechSmart.com's processing facilities where the assets are audited, tested, cleaned, packaged and remarketed through the Company's web site. Historically, businesses with recovered assets operated an inefficient in-house program in conjunction with a multi-tiered chain of "mom and pop" refurbishers, brokers, resellers and service providers. Because recovered asset management is not a core competency of these asset owners, they incurred excessive processing costs and achieved sales far below fair market value.

PhotonEx is a prominent event in the UK, focusing on photonics and light technologies. It serves as a platform to showcase innovations and advancements in this field, bringing together industry experts, researchers, and businesses to discuss and explore the latest developments. In addition to organizing this event, PhotonEx is involved in the development of smart photonic systems aimed at enhancing public telecommunications networks. By integrating cutting-edge photonic technologies, the company aims to improve the efficiency and performance of telecommunications infrastructure. Through its initiatives, PhotonEx plays a crucial role in promoting the growth and application of photonics in various sectors.

Athenix is a prominent player in the field of agricultural and industrial biotechnology, specializing in the development of products, technologies, and processes tailored for agricultural and chemical applications. The company is dedicated to discovering new genes and transforming them into practical solutions that address specific customer requirements. Athenix focuses on creating plants, microbes, enzymes, and processes aimed at enhancing insect and nematode resistance, as well as herbicide tolerance. Additionally, its research extends to the identification of genes and proteins utilized in the chemical and animal feed industries, reinforcing its commitment to innovation in biotechnology.

Verio is the leader in providing online business solutions to SMBs worldwide. Distributed through its global network of viaVerio channel partners, Verio's solutions provide hosting, applications and managed services that enable SMBs to drive online success. Verio is a subsidiary of NTT Communications, one of the largest companies in the world and supports its operations with their highly reliable and scalable Global IP Network providing customers and partners with access to business solutions in more than 200 countries. In January 2009, Verio was named "Best Web Hosting Company 2008" by HostReview.com. For more information, visit: www.verio.com.

iParty is a retail provider of party goods, operating stores and websites primarily in New England and Florida. The company offers a diverse range of products, including paper party supplies, costumes for Halloween, decorative items like balloons, as well as accessories such as wigs, hats, and shoes. iParty aims to serve consumers looking for a variety of celebratory items for different occasions, supported by both physical retail locations and an online presence.